Weight-Loss Drug Access Could Be in Question in Pa.

Low-income residents could lose access to weight-loss drugs as Harrisburg looks for savings

Gov. Josh Shapiro’s administration plans to save money by cutting poor patients’ access to expensive weight-loss drugs like Ozempic. Not everyone is on board.

Online sales of obesity drug alternatives carry on despite FDA deadlines

Since the FDA said shortages of Wegovy and Zepbound are over, compounding pharmacies are supposed to stop making copies of the drugs. But some of those business are trying to find ways to continue.

Weight-loss drug access could be in question in Pa.

HARRISBURG — Low-income Pennsylvanians could lose access to medical coverage for popular weight-loss drugs like Ozempic and Wegovy as state lawmakers search for savings in this year’s state budget talks. ...

Weight loss program is associated with decrease α-tocopherol status in obese adults

Studies on changes in plasma α-tocopherol levels during body fat reduction in obese persons are not clear. The aim of the present study was to assess …

Low-Income Pennsylvanians Could Lose Access to Weight-Loss Drugs as Harrisburg Searches for Savings

Spotlight PA is an independent, nonpartisan, and nonprofit newsroom producing investigative and public-service journalism that holds power to account and drives positive change in Pennsylvania. Sign up for our free newsletters. HARRISBURG — Low-income Pennsylvanians could lose access to medical coverage for popular weight-loss drugs like Ozempic and Wegovy as state lawmakers search for savings in this year’s state budget talks. But while there’s…

Low-Income Residents Could Lose Access To Weight-Loss Drugs Amid Search For Savings

Gov. Josh Shapiro’s administration plans to save money by cutting poor patients’ access to expensive weight-loss drugs like Ozempic. Not everyone is on board. The post Low-Income Residents Could Lose Access To Weight-Loss Drugs Amid Search For Savings appeared first on NewtownPANow.com.